Ruffer’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Ruffer's ANIP Position: Q3 2026 in Review
Ruffer increased its ANI Pharmaceuticals (ANIP) stake by 140% in Q3 2026, buying an estimated $7.48M and bringing the position to 166,587 shares worth $6.87M. The position accounts for 0.35% of the portfolio, ranked #69.
Ruffer first reported a position in ANIP in Q1 2026 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Ruffer held 166,587 shares of ANI Pharmaceuticals worth $6.87M as of Q3 2026.
- Ruffer bought 97,161 ANI Pharmaceuticals shares in Q3 2026, an estimated $7.48M.
- ANI Pharmaceuticals made up 0.35% of Ruffer's portfolio in Q3 2026, its #69 holding.
- Ruffer first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 216 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.